These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37051250)

  • 21. Cavitation assisted endoplasmic reticulum targeted sonodynamic droplets to enhanced anti-PD-L1 immunotherapy in pancreatic cancer.
    Chen J; Feng L; Jin P; Shen J; Lu J; Song Y; Wang G; Chen Q; Huang D; Zhang Y; Zhang C; Xu Y; Huang P
    J Nanobiotechnology; 2022 Jun; 20(1):283. PubMed ID: 35710424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focused Acoustic Vortex-Regulated Composite Nanodroplets Combined with Checkpoint Blockade for High-Performance Tumor Synergistic Therapy.
    Wu P; Ya Z; Li Y; Zhu M; Zhang L; Zong Y; Guo S; Wan M
    ACS Appl Mater Interfaces; 2022 Jul; 14(27):30466-30479. PubMed ID: 35699948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
    Chen X; Huang Y; Chen H; Chen Z; Chen J; Wang H; Li D; Su Z
    J Nanobiotechnology; 2022 Jan; 20(1):34. PubMed ID: 35033089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy.
    Jiang Q; Qiao B; Lin X; Cao J; Zhang N; Guo H; Liu W; Zhu L; Xie X; Wan L; Tang R; Liang B; Wang D; Wang Z; Zhou Y; Ran H; Li P
    Theranostics; 2022; 12(1):59-75. PubMed ID: 34987634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosonodynamic Therapy Designed with Activatable Sonosensitizer and Immune Stimulant Imiquimod.
    Lei H; Kim JH; Son S; Chen L; Pei Z; Yang Y; Liu Z; Cheng L; Kim JS
    ACS Nano; 2022 Jul; 16(7):10979-10993. PubMed ID: 35723442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor.
    Shi L; Chen L; Wu C; Zhu Y; Xu B; Zheng X; Sun M; Wen W; Dai X; Yang M; Lv Q; Lu B; Jiang J
    Clin Cancer Res; 2016 Mar; 22(5):1173-1184. PubMed ID: 26933175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
    Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
    J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
    Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
    J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxygen-carrying nanoparticle-based chemo-sonodynamic therapy for tumor suppression and autoimmunity activation.
    Zhang Y; Qiu N; Zhang Y; Yan H; Ji J; Xi Y; Yang X; Zhao X; Zhai G
    Biomater Sci; 2021 Jun; 9(11):3989-4004. PubMed ID: 33908449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage-derived biomimetic nanoparticles enhanced SDT combined with immunotherapy inhibited tumor growth and metastasis.
    Chen S; Ma T; Wang J; Liang S; Liao H; Tan W; Chen M; Zhou X; Xu Y; Wang L; Niu C
    Biomaterials; 2024 Mar; 305():122456. PubMed ID: 38184961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy.
    Tang R; He H; Lin X; Wu N; Wan L; Chen Q; Hu Y; Cheng C; Cao Y; Guo X; Zhou Y; Xiong X; Zheng M; Wang Q; Li F; Zhou Y; Li P
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36650023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering oxygen-deficient ZrO
    Jiao X; Sun L; Zhang W; Ren J; Zhang L; Cao Y; Xu Z; Kang Y; Xue P
    Biomaterials; 2021 May; 272():120787. PubMed ID: 33819815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
    Lin X; Mao D; Bai R
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
    Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
    Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.
    Lu L; Xu X; Zhang B; Zhang R; Ji H; Wang X
    J Transl Med; 2014 Feb; 12():36. PubMed ID: 24502656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycyrrhetinic acid nanoparticles combined with ferrotherapy for improved cancer immunotherapy.
    Li Q; Su R; Bao X; Cao K; Du Y; Wang N; Wang J; Xing F; Yan F; Huang K; Feng S
    Acta Biomater; 2022 May; 144():109-120. PubMed ID: 35314366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.